Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.70 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.49 |
| ▸ | DPP4 | P27487 | 3/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | FAP | Q12884 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.45 |
| ▸ | TACR1 | P25103 | 1/20 | 0.44 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14095454 | 1.00 | TYR (0.70) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL22593493 | 0.94 | TYR (0.64) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL215971 | 0.94 | TYR (0.64) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL1491546 | 0.94 | TYR (0.64) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL7114295 | 0.94 | TYR (0.64) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL23642931 | 0.92 | TYR (0.62) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL22375169 | 0.92 | TYR (0.62) | TYRALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL17707256 | 0.92 | TYR (0.62) | TYRALPIPKMPTGS1XIAP | |
| SCHEMBL22375034 | 0.92 | TYR (0.62) | TYRALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL5283593 | 0.92 | TYR (0.62) | TYRALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0135429-A1 | The synthesis of cyclopropane amino acids and peptides | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1985-03-27 | — | — | EP | claimed |
| WO-1985000809-A1 | THE SYNTHESIS OF CYCLOPROPANE AMINO ACIDS AND PEPTIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1985-02-28 | — | — | WO | claimed |
| US-20110201581-A1 | Novel Compounds 010 | ASTRAZENECA AB (SE) | 2011-08-18 | — | — | US | disclosed |
| US-7902181-B2 | Compounds 010 | ASTRAZENECA AB (SE) | 2011-03-08 | — | — | US | disclosed |
| EP-2231597-A1 | PEPTIDYL NITRILES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE I INHIBITORS | AstraZeneca AB (SE) | 2010-09-29 | — | — | EP | disclosed |
| US-20090306042-A1 | Novel Compounds 010 | ASTRAZENECA AB (SE) | 2009-12-10 | — | — | US | disclosed |
| WO-2009074829-A1 | PEPTIDYL NITRILES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE I INHIBITORS | ASTRAZENECA AB (SE) | 2009-06-18 | — | — | WO | disclosed |
| US-4629784-A | ENZYME INHIBITORS; HORMONES; STABILIZERS; | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1986-12-16 | — | — | US | disclosed |
| EP-0135429-A1 | The synthesis of cyclopropane amino acids and peptides | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1985-03-27 | — | — | EP | disclosed |
| WO-1985000809-A1 | THE SYNTHESIS OF CYCLOPROPANE AMINO ACIDS AND PEPTIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1985-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306042-A1 | Novel Compounds 010 | MRGPRX2, F12, TBXA2R | TYR 1966/4885ALPI 1965/4885PKM 3780/4885 |
| US-20110201581-A1 | Novel Compounds 010 | MRGPRX2, F12, TBXA2R | TYR 1966/4885ALPI 1965/4885PKM 3780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.